CSI Market
Sign In | Register

Immunome Inc (IMNM) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMNM quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Immunome Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent653.48
Available-for-sale Securities, Debt Securities, Current MA0.00
Other Short-term Investments0.00
Cash & Short-term Investments653.00
Notes Receivable, Current0.00
Derivatives, Collateral, Regulatory, Deferred0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.30
Total Current Assets660.78
Equipment/Property/Plant Net14.64
Tax Assets, Noncurrent0.00
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent7.78
Restricted Cash Noncurrent0.21
Total Assets683.19
Liabilities
Accounts Payable, Current AC3.34
Accrued Liabilities And Other Liabilities41.65
Other Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities44.99
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent3.86
OperatingLeaseLiabilityNoncurrent3.86
Current Portion Of Equipment Loan Payable-
Total Liabilities48.85
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,362.50
Retained Earnings / Accumulated Deficit-728.16
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity634.34
Total Stockholder's Equity634.34
Liabilities & Stockholder's Equity683.19
4 historic quarters locked

Sign in to unlock the full Immunome Inc balance sheet history.

Sign In Create Free Account

About Immunome Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-088172

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License